You are here: Industry Insights > CGT catapult

News List

New consortium to develop PAT for cell and gene therapies europeanpharmaceuticalreview
June 17, 2021
The Cell and Gene Therapy Catapult’s new consortium aims to accelerate therapeutic development by developing process analytical technologies (PAT) for cell and gene therapy manufacturing.
Cell and Gene Therapy Catapult forms consortium of over 20 organisations pharmatimes
June 10, 2021
The Cell and Gene Therapy (CGT) Catapult has announced the formation of a consortium of over 20 organisations, which will aim to accelerate technology development in cell and gene therapy manufacturing.
Rentschler Biopharma to build cell and gene therapy manufacturing capabilities in the UK pharmatimes
February 24, 2021
Rentschler Biopharma, a German contract development and manufacturing organisation (CDMO), will build new cell and gene therapy capabilities at a Cell and Gene Therapy (CGT) Catapult site in Stevenage, UK.
UK sees a 20% growth in the number of advanced therapy trials, report finds pharmatimes
February 24, 2021
The UK has had a 20% growth in the number of advanced therapy medicinal product (ATMP) clinical trials, according to a new report from the Cell and Gene Therapy Catapult (CGT Catapult).
Cell and Gene Therapy Catapult links with Japan's CiRA Foundation pharmatimes
May 14, 2020
The Cell and Gene Therapy Catapult (CGT Catapult) and Kyoto, Japan-based CiRA Foundation are launching a new collaborative research project focused on induced pluripotent stem (iPS) cell characterisation.
Investment in UK cell and gene therapy manufacturing set to continue europeanpharmaceuticalreview
December 09, 2019
An additional 6,000m2 of cell and gene therapy manufacturing space is expected to become available within the next 12 months, according to new data.
UK surge in cell and gene therapy trials pharmatimes
January 08, 2019
A surge in cell and gene therapy trials - an increase of 37% since 2017 - highlights the UK’s leading position as a developmental hub in this innovative industry, according to the Cell and Gene Therapy Catapult.
Cell and Gene Therapy Catapult addresses sector skills gap pharmatimes
November 26, 2018
The Cell and Gene Therapy (CGT) Catapult has launched the first Advanced Therapy Medicinal Products (ATMP) focused apprenticeship programme...